Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release.

The effects of 5-hydroxytryptamine (5-HT) on the release of [3H]acetylcholine ([3H]ACh) from rat hippocampal nerve endings were investigated using synaptosomes labelled with [3H]choline and depolarized in superfusion with 15 mM KCl. The release of [3H]ACh was concentration dependently inhibited by exogenous 5-HT. The concentration-response curve of 5-HT was shifted to the right in a parallel way by methiothepin. The 5-HT2 antagonists ketanserin or methysergide did not antagonize the effect of 5-HT. The 5-HT1 agonist 5-methoxy-3-[1,2,3,6-tetrahydropyridin-4-yl]-1H-indole (RU 24969) mimicked 5-HT, whereas the 5-HT1A selective agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) was ineffective. When used as a 5-HT1A/5-HT1B antagonist, (-)propranolol antagonized 5-HT whereas spiperone (a 5-HT1A displacer) did not. The 5-HT1C selective antagonist mesulergine was also ineffective towards 5-HT. It can be concluded that hippocampal cholinergic terminals are endowed with inhibitory 5-HT receptors which appear to belong to the 5-HT1B subtype.

[1]  P. Timmermans,et al.  Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites. Correlation between 5-HT1A affinity and hypotensive activity. , 1985, European journal of pharmacology.

[2]  E. Azmitia.  The Serotonin-Producing Neurons of the Midbrain Median and Dorsal Raphe Nuclei , 1978 .

[3]  V. P. Whittaker,et al.  The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. , 1962, Journal of anatomy.

[4]  J. Gray,et al.  Septal elicitation of hippocampal theta rhythm after localized de-afferentation of serotoninergic fibers , 1980, Brain Research.

[5]  H. Yamamura,et al.  Discrimination of Multiple [3H]5‐Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain , 1981, Journal of neurochemistry.

[6]  A. Phillips,et al.  Disruption of memory produced by stimulation of the dorsal raphe nucleus: mediation by serotonin , 1978, Brain Research.

[7]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[8]  I. Gardiner,et al.  CHOLINERGIC ACTION IN THE NUCLEUS ACCUMBENS: MODULATION OF DOPAMINE AND ACETYLCHOLINE RELEASE , 1982, British journal of pharmacology.

[9]  C. Oberlander,et al.  The interaction of indole derivatives with the serotonin receptor and non-dopaminergic circling behaviour. , 1981, Advances in experimental medicine and biology.

[10]  S. Robinson.  Effect of specific serotonergic lesions on cholinergic neurons in the hippocampus, cortex and striatum. , 1983, Life sciences.

[11]  S H Snyder,et al.  Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.

[12]  M. Raiteri,et al.  Calcium-dependent [3H]acetylcholine release and muscarinic autoreceptors in rat cortical synaptosomes during development , 1983, Neurochemical Research.

[13]  G. Fillion,et al.  Serotonin Inhibits Acetylcholine Release from Rat Striatum Slices: Evidence for a Presynaptic Receptor‐Mediated Effect , 1985, Journal of neurochemistry.

[14]  E. Vizi,et al.  Evidence of the modulatory role of serotonin in acetylcholine release from striatal interneurons , 1981, Brain Research.

[15]  J. Palacios,et al.  The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. , 1984, European journal of pharmacology.

[16]  J. Black,et al.  Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach , 1985, British journal of pharmacology.

[17]  J. Richard,et al.  Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex , 1985, Brain Research.

[18]  D. Middlemiss,et al.  8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. , 1983, European journal of pharmacology.

[19]  M. Raiteri,et al.  A simple apparatus for studying the release of neurotransmitters from synaptosomes. , 1974, European journal of pharmacology.